CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Potenza Medica Ltd. develops innovative fertility products, particularly OvaRenew, aimed at improving egg quality in women with infertility issues. This therapy utilizes stem cell research to enhance oocyte production, offering a less invasive and cost-effective solution for women seeking to conceive.
Potenza Medica Ltd. is specialised in the development and commercialisation of innovative fertility products.
Our solution is tackling one of the deepest human needs-reproduction.
With OvaRenew as a first-line therapy in ovarian infertility, we intend to grab business opportunity to be the first in the world with disruptive fertility solution for women with impaired egg quality.
Global fertility services market was in 2015 estimated to be between 27-36 billion € with growth rates of 8-9% in EU a…
POTENZA MEDICA D.O.O.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
